Alberta Investment Management Corp (AIMCo)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,250
Closed -$22.8M 747
2025
Q4
$22.8M Buy
21,250
+10,450
+97% +$9.99M 0.14% 123
2025
Q3
$8.24M Sell
10,800
-7,100
-40% -$5.28M 0.06% 180
2025
Q2
$14M Buy
17,900
+5,000
+39% +$3.89M 0.11% 135
2025
Q1
$10.7M Sell
12,900
-2,100
-14% -$1.75M 0.07% 196
2024
Q4
$11.6M Sell
15,000
-1,400
-9% -$1.16M 0.08% 168
2024
Q3
$14.5M Buy
16,400
+12,100
+281% +$10.9M 0.13% 128
2024
Q2
$3.89M Sell
4,300
-15,600
-78% -$12.5M 0.04% 241
2024
Q1
$15.5M Buy
19,900
+200
+1% +$142K 0.16% 121
2023
Q4
$11.5M Sell
19,700
-35,087
-64% -$20.5M 0.11% 129
2023
Q3
$29.4M Sell
54,787
-1,240
-2% -$639K 0.32% 75
2023
Q2
$26.3M Sell
56,027
-13,415
-19% -$5.63M 0.25% 88
2023
Q1
$23.8M Buy
69,442
+9,714
+16% +$3.28M 0.23% 93
2022
Q4
$21.9M Sell
59,728
-7,354
-11% -$2.61M 0.19% 106
2022
Q3
$21.7M Sell
67,082
-57,688
-46% -$18.3M 0.17% 127
2022
Q2
$40.5M Buy
124,770
+39,263
+46% +$11.8M 0.29% 70
2022
Q1
$24.5M Sell
85,507
-3,022
-3% -$778K 0.14% 152
2021
Q4
$24.5M Buy
88,529
+17,729
+25% +$4.49M 0.15% 145
2021
Q3
$16.4M Buy
70,800
+500
+0.7% +$123K 0.14% 154
2021
Q2
$16.1M Sell
70,300
-11,500
-14% -$2.31M 0.13% 168
2021
Q1
$15.3M Buy
81,800
+9,300
+13% +$1.82M 0.14% 161
2020
Q4
$12.2M Hold
72,500
0.11% 218
2020
Q3
$10.7M Sell
72,500
-9,700
-12% -$1.5M 0.12% 210
2020
Q2
$13.5M Buy
82,200
+20,000
+32% +$3.07M 0.16% 150
2020
Q1
$8.63M Buy
62,200
+36,000
+137% +$4.95M 0.15% 168
2019
Q4
$3.44M Hold
26,200
0.03% 419
2019
Q3
$2.93M Buy
+26,200
New +$2.92M 0.03% 432
2019
Q2
Sell
-9,100
Closed -$1.18M 971
2019
Q1
$1.18M Buy
+9,100
New +$1.11M 0.01% 582
2018
Q4
Sell
-236,100
Closed -$25.3M 798
2018
Q3
$25.3M Sell
236,100
-101,600
-30% -$10.2M 0.22% 116
2018
Q2
$28.8M Buy
337,700
+263,900
+358% +$21.7M 0.25% 99
2018
Q1
$5.71M Buy
73,800
+58,000
+367% +$4.67M 0.05% 317
2017
Q4
$1.33M Sell
15,800
-15,500
-50% -$1.32M 0.01% 511
2017
Q3
$2.68M Buy
31,300
+12,600
+67% +$1.03M 0.03% 423
2017
Q2
$1.54M Hold
18,700
0.01% 465
2017
Q1
$1.57M Buy
18,700
+15,200
+434% +$1.22M 0.01% 484
2016
Q4
$257K Sell
3,500
-7,500
-68% -$559K ﹤0.01% 668
2016
Q3
$883K Sell
11,000
-3,700
-25% -$296K 0.01% 546
2016
Q2
$1.16M Buy
+14,700
New +$1.11M 0.01% 490
2016
Q1
Sell
-137,700
Closed -$11.6M 523
2015
Q4
$11.6M Buy
+137,700
New +$11.4M 0.14% 186
2015
Q2
Sell
-147,500
Closed -$10.7M 517
2015
Q1
$10.7M Buy
+147,500
New +$10.5M 0.11% 251
2014
Q3
Sell
-370,200
Closed -$23M 505
2014
Q2
$23M Hold
370,200
0.25% 96
2014
Q1
$21.8M Sell
370,200
-33,500
-8% -$1.87M 0.26% 99
2013
Q4
$20.6M Buy
403,700
+107,800
+36% +$5.4M 0.26% 101
2013
Q3
$14.9M Buy
295,900
+3,500
+1% +$183K 0.19% 158
2013
Q2
$15.1M Buy
+292,400
New +$15.9M 0.37% 68

Other funds holding LLY

Alberta Investment Management Corp (AIMCo)'s LLY Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 21,250 shares — an estimated $22.8M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in LLY in Q2 2013 and held it in 44 quarters. The position peaked at $40.5M in Q2 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 21,250 Eli Lilly shares in Q1 2026, an estimated $22.8M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Eli Lilly in Q2 2013 and held it in 44 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Eli Lilly position peaked at $40.5M in Q2 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.